Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

BH4-mimetics and -antagonists: an emerging class of Bcl-2 protein modulators for cancer therapy.

Nougarède A, Rimokh R, Gillet G.

Oncotarget. 2018 Oct 19;9(82):35291-35292. doi: 10.18632/oncotarget.26250. eCollection 2018 Oct 19. No abstract available.

2.

Improved IRE1 and PERK Pathway Sensors for Multiplex Endoplasmic Reticulum Stress Assay Reveal Stress Response to Nuclear Dyes Used for Image Segmentation.

Nougarède A, Tesnière C, Ylanko J, Rimokh R, Gillet G, Andrews DW.

Assay Drug Dev Technol. 2018 Aug/Sep;16(6):350-360. doi: 10.1089/adt.2018.862. Epub 2018 Aug 8.

PMID:
30088945
3.

Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10.

Nougarede A, Popgeorgiev N, Kassem L, Omarjee S, Borel S, Mikaelian I, Lopez J, Gadet R, Marcillat O, Treilleux I, Villoutreix BO, Rimokh R, Gillet G.

Cancer Res. 2018 Mar 15;78(6):1404-1417. doi: 10.1158/0008-5472.CAN-17-0846. Epub 2018 Jan 12.

4.

The Bcl-2 homolog Nrz inhibits binding of IP3 to its receptor to control calcium signaling during zebrafish epiboly.

Bonneau B, Nougarède A, Prudent J, Popgeorgiev N, Peyriéras N, Rimokh R, Gillet G.

Sci Signal. 2014 Feb 11;7(312):ra14. doi: 10.1126/scisignal.2004480.

PMID:
24518293
5.

Experimental cytology of the shoot apical cells during vegetative growth and flowering.

Nougarède A.

Int Rev Cytol. 1967;21:203-351. Review. No abstract available.

PMID:
5338240
6.

[Contribution to the study of facial development].

Nougarède A.

Orthod Fr. 1967;38:333-46. French. No abstract available.

PMID:
5249771

Supplemental Content

Loading ...
Support Center